Search

Hoshida, Y., J. P. Brunet, P. Tamayo, T. R. Golub, and J. P. Mesirov. 2007. “Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets”. PLoS One 2: e1195.

Hoshida, Y., S. M. Nijman, M. Kobayashi, J. A. Chan, J. P. Brunet, D. Y. Chiang, A. Villanueva, et al. 2009. “Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma”. Cancer Res 69: 7385-92.

Hoshida, Y., A. Villanueva, A. Sangiovanni, M. Sole, C. Hur, K. L. Andersson, R. T. Chung, et al. 2013. “Prognostic Gene Expression Signature for Patients With Hepatitis C-Related Early-Stage Cirrhosis”. Gastroenterology 144: 1024-30.

Humpherys, D., K. Eggan, H. Akutsu, A. Friedman, K. Hochedlinger, R. Yanagimachi, E. S. Lander, T. R. Golub, and R. Jaenisch. 2002. “Abnormal Gene Expression in Cloned Mice Derived from Embryonic Stem Cell and Cumulus Cell Nuclei”. Proc Natl Acad Sci U S A 99: 12889-94.

Niepel, M., M. Hafner, Q. Duan, Z. Wang, E. O. Paull, M. Chung, X. Lu, et al. 2017. “Common and Cell-Type Specific Responses to Anti-Cancer Drugs Revealed by High Throughput Transcript Profiling”. Nat Commun 8: 1186.

Oberlick, E. M., M. G. Rees, B. Seashore-Ludlow, F. Vazquez, G. M. Nelson, N. V. Dharia, B. A. Weir, et al. 2019. “Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors”. Cell Rep 28: 2331-2344 e8.

Olson, P., J. Lu, H. Zhang, A. Shai, M. G. Chun, Y. Wang, S. K. Libutti, E. K. Nakakura, T. R. Golub, and D. Hanahan. 2009. “MicroRNA Dynamics in the Stages of Tumorigenesis Correlate With Hallmark Capabilities of Cancer”. Genes Dev 23: 2152-65.

Parikh, A. R., I. Leshchiner, L. Elagina, L. Goyal, C. Levovitz, G. Siravegna, D. Livitz, et al. 2019. “Author Correction: Liquid versus Tissue Biopsy for Detecting Acquired Resistance and Tumor Heterogeneity in Gastrointestinal Cancers”. Nat Med 25: 1949.

Parsons, H. A., J. Rhoades, S. C. Reed, G. Gydush, P. Ram, P. Exman, K. Xiong, et al. 2020. “Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer”. Clin Cancer Res 26: 2556-64.

Penney, K. L., J. A. Sinnott, K. Fall, Y. Pawitan, Y. Hoshida, P. Kraft, J. R. Stark, et al. 2011. “MRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer”. J Clin Oncol 29: 2391-6.